| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 13.11. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: EXTRAORDINARY/SPECIAL GENERAL MEETING::VOLUNTARY | - | SGX Company Announcements | ||
| 12.11. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: CHANGE - AMENDMENT TO ARTICLES::PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION OF THE COMPANY | - | SGX Company Announcements | ||
| 12.11. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::RESOLUTIONS PASSED AT THE 10TH BOARD MEETING FOR FY2026 | - | SGX Company Announcements | ||
| TIANJIN PHARMACEUTICAL DA REN TANG Aktie jetzt für 0€ handeln | |||||
| 30.10. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::MONTHLY UPDATE ON BANKRUPTCY LIQUIDATION OF A SUBSIDIARY OF THE COMPANY | 3 | SGX Company Announcements | ||
| 30.10. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::THE PROPOSED ENTRY INTO A NEW MEDIA PROMOTION SERVICES AGREEMENT AS AN INTERESTED PERSON TRANSACTION | 3 | SGX Company Announcements | ||
| 30.10. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::THIRD QUARTER RESULTS | 1 | SGX Company Announcements | ||
| 30.10. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::RESOLUTIONS PASSED AT THE 9TH BOARD MEETING FOR FY2026 | 4 | SGX Company Announcements | ||
| 23.10. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: REPL::EXTRAORDINARY/SPECIAL GENERAL MEETING::VOLUNTARY | 2 | SGX Company Announcements | ||
| 19.10. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: REPL::EXTRAORDINARY/SPECIAL GENERAL MEETING::VOLUNTARY | 2 | SGX Company Announcements | ||
| 09.10. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::ANNOUNCEMENT ON RECEIPT OF DRUG REGISTRATION CERTIFICATES BY XINXIN PHARMACEUTICAL PLANT | 4 | SGX Company Announcements | ||
| 08.10. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: REPL::EXTRAORDINARY/SPECIAL GENERAL MEETING::VOLUNTARY | 1 | SGX Company Announcements | ||
| 29.09. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::MONTHLY UPDATE ON BANKRUPTCY LIQUIDATION OF A SUBSIDIARY OF THE COMPANY | 1 | SGX Company Announcements | ||
| 24.09. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::UPDATE ON THE PROPOSED TRANSFER OF 100% EQUITY INTEREST IN AN UPSTREAM SHAREHOLDER | 2 | SGX Company Announcements | ||
| 07.09. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: EXTRAORDINARY/SPECIAL GENERAL MEETING::VOLUNTARY | 3 | SGX Company Announcements | ||
| 04.09. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: CHANGE - ANNOUNCEMENT OF APPOINTMENT::APPOINTMENT OF GENERAL MANAGER | 1 | SGX Company Announcements | ||
| 04.09. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION OF THE COMPANY | 1 | SGX Company Announcements | ||
| 04.09. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::RESOLUTIONS PASSED AT THE 8TH BOARD MEETING FOR FY2026 | 1 | SGX Company Announcements | ||
| 31.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::MONTHLY UPDATE ON BANKRUPTCY LIQUIDATION OF A SUBSIDIARY OF THE COMPANY | - | SGX Company Announcements | ||
| 28.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::MINUTES OF THE 1ST EXTRAORDINARY GENERAL MEETING OF THE COMPANY FOR FY2026 HELD ON 31 JULY 2026 | 1 | SGX Company Announcements | ||
| 26.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::ANNOUNCEMENT ON CONVENING AN ONLINE CONFERENCE | - | SGX Company Announcements |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ASTRAZENECA | 159,75 | -0,06 % | Wichtige Zulassung: Neuer Hoffnungsträger: AstraZeneca punktet in Europa und den USA | © Foto: Marcus Brandt - dpaGrünes Licht aus den USA und Europa: AstraZeneca darf ein neuartiges Medikament gegen eine seltene Autoimmunerkrankung auf den Markt bringen Enthaltene Werte: GB0009895292Den... ► Artikel lesen | |
| TEVA PHARMACEUTICAL INDUSTRIES | 38,550 | +0,05 % | Teva Announces R&D Leadership Transition As Chief Medical Officer Departs | PETAH TIKVA (dpa-AFX) - Teva Pharmaceuticals Industries (TEVA) announced that Dr. Eric Hughes, Executive Vice President, Global R&D and Chief Medical Officer, will leave the company after accepting... ► Artikel lesen | |
| SINOPHARM | 1,930 | 0,00 % | Harbour BioMed and Sinopharm Enter Strategic Collaboration to Establish Innovation R&D Consortium | CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, July 27, 2026 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed... ► Artikel lesen | |
| CSPC PHARMA | 0,914 | 0,00 % | CSPC PHARMA Receives USD15 million Development Milestone Payment for CRB-701 | ||
| WUXI BIOLOGICS | 5,040 | +1,61 % | Der China-Schatz: Fresenius sichert sich 37 neue Biosimilar-Kandidaten | © Foto: Arne Dedert/dpaFresenius sichert sich über einen Exklusivvertrag mit WuXi Biologics Zugriff auf bis zu 37 neue Biosimilars. Die Pipeline könnte sich mehr als verdoppeln. DZ Bank und Jefferies... ► Artikel lesen | |
| OPKO HEALTH | 1,510 | +2,72 % | Labcorp To Acquire BioReference Health Assets; OPKO Shares Rise 7.35% | WASHINGTON (dpa-AFX) - Labcorp Holdings Inc. (LH), a provider of innovative and comprehensive laboratory services, on Thursday announced that it had agreed to acquire select assets of BioReference... ► Artikel lesen | |
| SHANGHAI FOSUN PHARMACEUTICAL | 1,660 | -1,34 % | FOSUN PHARMA Repurchases 1.845 Million Shares on Thu for HKD27.769 Million | ||
| GEDEON RICHTER | 36,900 | -0,27 % | Richter Agrees to Acquire Mayne Pharma for AUD 604 mln | ||
| DR REDDYS | 13,500 | -0,74 % | Gilead Inks Deals with Dr. Reddy's, Eva Pharma, Ferozsons to Expand Ebola BVD Treatment | ||
| BAYER | 54,68 | -2,25 % | DAX trotzt schwachem US-Tech-Sektor: Bayer - Aktie lässt nichts anbrennen. Nun auf 60 Euro? | Der DAX geht mit einer robusten Freitagsperformance ins Wochenende. Der Wochenschluss im Bereich von 26.700 Punkten hält die Tür für eine Jahresendrallye offen. Ein Selbstläufer wird diese jedoch nicht.... ► Artikel lesen | |
| MERCK KGAA | 148,40 | -0,74 % | Merck KGaA-Aktie: Halbleiter glänzen, US-Umsatz schmilzt | Merck KGaA hebt die Prognose an, als gäbe es dafür Treuepunkte - zum dritten Mal in diesem Jahr. Doch während die Chipsparte brummt, schmilzt der US-Umsatz in der Pharma-Sparte mit Mavenclad dahin.... ► Artikel lesen | |
| NOVO NORDISK | 35,490 | 0,00 % | Pharma-Turnaround-Aktien im Check - Evotec, Vidac Pharma, Novo Nordisk zwischen Umbau, Studie und Prognose | Zwischen dem 4. und dem 9. November haben gleich drei Pharma- und Biotechwerte Nachrichten vorgelegt, die nach einem Wendepunkt klingen. Beim einen schrumpfte der Quartalsverlust vor Sonderposten, beim... ► Artikel lesen | |
| LB PHARMACEUTICALS | 40,040 | 0,00 % | LB Pharmaceuticals Inc: LB Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update | Announced accelerated timing of topline data readout from the pivotal Phase 3 NOVA-2 trial of LB-102 in schizophrenia in the first half of 2027 Announced plans for pipeline expansion of LB-102 into... ► Artikel lesen | |
| ELI LILLY | 1.233,80 | +0,21 % | Neue Hoffnung: Nach dem Abnehm-Boom: Eli Lilly zündet die nächste Milliardenstufe | © Foto: Sascha Lotz/dpaEli Lilly steckt 3,5 Milliarden US-Dollar in einen neuen Produktionsstandort. Dabei geht es um einen Wirkstoff, der das nächste große Geschäft werden könnte Enthaltene Werte:... ► Artikel lesen | |
| PFIZER | 25,145 | +0,08 % | 27 % weniger neue Medikamente: Trump setzt Europa unter Druck: Jetzt droht ein Medikamenten-Engpass | © Foto: Patrick Seeger/dpaTrumps Arzneimittelpolitik trifft Europa: Die Markteinführung neuer Medikamente sinkt um 27 Prozent. Pharmakonzerne schützen ihre Gewinne, Patienten leiden Enthaltene Werte:... ► Artikel lesen |